Related Experiment Video
Updated: Jun 6, 2026

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
Published on: March 19, 2016
Continuing education course #2: current understanding of hemostasis
1Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA. agale@scripps.edu
This review summarizes hemostasis pathways, anticoagulant mechanisms, and fibrinolysis. It also discusses hemostasis disorders and therapeutic drugs, highlighting recent advancements for patient benefit.
Area of Science:
- Hematology
- Vascular Biology
- Pharmacology
Background:
- Hemostasis is a complex process crucial for preventing blood loss.
- It involves intricate interactions between platelets, coagulation factors, and the vascular system.
- Dysregulation of hemostasis can lead to thrombotic or bleeding disorders.
Purpose of the Study:
- To provide a concise overview of primary and secondary hemostasis.
- To summarize key anticoagulant mechanisms and fibrinolytic processes.
- To discuss pathologies of hemostasis and the therapeutic strategies targeting these pathways.
Main Methods:
- Literature review of hemostasis, anticoagulation, and fibrinolysis.
- Analysis of current and emerging pharmacological agents.
- Discussion of clinical implications for thrombosis and bleeding.
Main Results:
- Detailed summary of the two main hemostasis pathways.
- Explanation of anticoagulant and fibrinolytic systems.
- Overview of various drugs impacting hemostasis, including novel agents.
Conclusions:
- Enhanced understanding of hemostasis drives the development of new therapies.
- Recent advancements in drug development offer improved patient outcomes.
- Continued research in hemostasis is vital for managing bleeding and thrombotic disorders.
More Related Videos
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
08:01The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
Published on: February 27, 2026
Related Concept Videos
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...